ScholarIQanswers from OpenAlex & ORCID
Manish A. Shah
ResearcherPublications, citations & collaboration network
Manish A. Shah is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Manish A. Shah have?
ScholarIQindexed works
Manish A. Shah has 662 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Manish A. Shah have?
ScholarIQcitation count
Manish A. Shah has 34,076 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Manish A. Shah?
ScholarIQh-index
Manish A. Shah has an h-index of 83 in OpenAlex.
What is the i10-index of Manish A. Shah?
ScholarIQi10-index
Manish A. Shah has an i10-index of 232 in OpenAlex.
What is the ORCID of Manish A. Shah?
ScholarIQorcid
The ORCID for Manish A. Shah is on the source record.
What is the OpenAlex record for Manish A. Shah?
ScholarIQopenalex
The OpenAlex for Manish A. Shah is on the source record.
What are the most-cited papers on Manish A. Shah?
ScholarIQmost cited works
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
Manish A. Shah, Nicole A. Datson, Lakshmi Srinidhi, VP Stanton, Marcy E. MacDonald, Marc W. Allard, S Youngman, Frischauf Am, Richard Mott, KM Draths, G. Zehetner, Claire O’Donovan, T Fielder, Bruce G. Jenkins, Manju Swaroop, Scott A. Taylor, L. Doucette-Stamm, H MacFarlane, SA Strobel, H. E. McFarlane, Buckler Aj, Nicolet Groot, Holger Hummerich, Deanna M. Church, Marilyn A. Anderson, Marianne F. James, Glenn Barnes, M. Carle Christine, FS Collins, MP Duyao, Peter B. Dervan, Gillian P. Bates, Tracey Holloway, P S Harper, TW Mcdonald, Michael North, K Blanchard, J.J. Wasmuth, Duncan Shaw, Hans Lehrach, Danilo A. Tagle, A. Poustka, Housman De, T. Huntington, Zdeněk Sedláček, Laura Riba, Suzanne L. Kirby, Carol Sze Ki Lin, RH Myers, Larry H. Thompson, Russell G. Snell, Michael O'Donovan, Kathleen M. Gillespie, Rita Shiang, NS Wexler, CM Ambrose, J.F. Gusella, Sarah Baxendale, N. Groat, John Valdes
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Jong‐Mu Sun, Lin Shen, Manish A. Shah, Peter C. Enzinger, Antoine Adenis, Toshihiko Doi, Takashi Kojima, Jean‐Philippe Metges, Zhigang Li, Sung‐Bae Kim, Byoung Chul Cho, Wasat Mansoor, Shau-Hsuan Li, Patrapim Sunpaweravong, María Maqueda, Eray Goekkurt, Hiroki Hara, Luís Carlos Moreira Antunes, Christos Fountzilas, Akihito Tsuji, Victor Castro Oliden, Qi Liu, Sukrut Shah, Pooja Bhagia, Ken Kato
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
Takashi Kojima, Manish A. Shah, Kei Muro, Éric François, Antoine Adenis, Chih‐Hung Hsu, Toshihiko Doi, Toshikazu Moriwaki, Sung‐Bae Kim, Se‐Hoon Lee, Jaafar Bennouna, Ken Kato, Lin Shen, Peter C. Enzinger, Shukui Qin, Paula Ferreira, Jia Chen, Gustavo Girotto, Christelle de la Fouchardière, Hélène Senellart, Raed Moh’d Taiseer Al-Rajabi, Florian Lordick, Ruixue Wang, Shailaja Suryawanshi, Pooja Bhagia, Soonmo Peter Kang, Jean‐Philippe Metges, on behalf of the KEYNOTE-181 Investigators
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
Holly G. Prigerson, Yuhua Bao, Manish A. Shah, M. Elizabeth Paulk, Thomas W. LeBlanc, Bryan J. Schneider, Melissa M. Garrido, M. Carrington Reid, David Berlin, Kerin B. Adelson, Alfred I. Neugut, Paul K. Maciejewski
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus
Manish A. Shah, Takashi Kojima, Daniel Hochhauser, Peter C. Enzinger, Judith Raimbourg, Antoine Hollebecque, Florian Lordick, Sung‐Bae Kim, Masahiro Tajika, Heung Tae Kim, A. Craig Lockhart, Hendrik-Tobias Arkenau, Farid El-Hajbi, Mukul Gupta, Per Pfeiffer, Qi Liu, Jared Lunceford, Soonmo Peter Kang, Pooja Bhagia, Ken Kato